VVOS
Vivos Therapeutics Inc
NASDAQ: VVOS · HEALTHCARE · MEDICAL DEVICES
$0.80
+2.26% today
Updated 2026-04-30
Market cap
$11.46M
P/E ratio
—
P/S ratio
0.66x
EPS (TTM)
$-2.07
Dividend yield
—
52W range
$1 – $8
Volume
0.2M
Vivos Therapeutics Inc (VVOS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-20.1%
Last 4 quarters
Revenue YoY growth
+3.4%
Most recent quarter
EPS YoY growth
-107.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-6.6%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-14.2%
2025-11-19
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-26 | $-0.58 | -17.2% | $1.14 | $1.15 | +0.9% |
| 2025-11-19 | $-0.49 | -2.1% | $2.47 | $2.12 | -14.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.50 | $-0.58 | -17.2% | $3.82M | +3.4% |
| 2025-09-30 | $-0.48 | $-0.49 | -2.1% | $6.78M | +75.7% |
| 2025-06-30 | $-0.39 | $-0.55 | -41.0% | $3.82M | -5.8% |
| 2025-03-31 | $-0.40 | $-0.48 | -20.0% | $3.02M | -11.8% |
| 2024-12-31 | $-0.43 | $-0.28 | +34.9% | $3.70M | +13.9% |
| 2024-09-30 | $-0.61 | $-0.40 | +34.4% | $3.86M | +16.9% |
| 2024-06-30 | $-1.05 | $-0.60 | +42.9% | $4.05M | +19.4% |
| 2024-03-31 | $-1.17 | $-1.63 | -39.3% | $3.42M | — |
| 2023-12-31 | $-1.90 | $-3.05 | -60.5% | $3.25M | — |
| 2023-09-30 | $-3.12 | $-1.62 | +48.1% | $3.30M | — |
| 2023-06-30 | $-0.14 | $-0.18 | -28.6% | $3.40M | — |
| 2023-03-31 | $-0.18 | $-0.07 | +61.1% | — | — |
Frequently asked questions
Has Vivos Therapeutics Inc beaten earnings estimates?
Vivos Therapeutics Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -20.1% over the last 4 quarters.
How does VVOS stock react to earnings?
VVOS stock has moved an average of -6.6% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Vivos Therapeutics Inc's revenue growth rate?
Vivos Therapeutics Inc reported year-over-year revenue growth of +3.4% in its most recent quarter, with EPS growing -107.1% year-over-year.